Skip to main content

Bachem Value Stock - Dividend - Research Selection

Bachem Holding AG

ISIN: CH0012530207, WKN: 914589

Market price date: 26.01.2022
Market price: 530,00 CHF


Bachem Holding AG Fundamental data and company key figures of the share

Annual reports in CHF
Key figures 10-09-2021
Cash flow
Net operating cash flow 115.040.000
Capital Expenditures -65.521.000
Free cash flow 49.519.000
Balance sheet
Total Equity 475.714.000
Liabilities & Shareholders equity 710.884.000
Income statement
Net income 78.062.000
Eps (diluted) 5,577
Diluted shares outstanding 13.996.400
Net sales/revenue 401.995.000

Fundamental ratios calculated on: 26-01-2022

Ratios
Key figures 26-01-2022
Cash flow
P/C 64,48
   
P/FC 149,80
Balance sheet
ROI10,98
ROE66,92
Income statement
P/E95,03
Div. Yield0,61%
P/B15,59
P/S18,45


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolBANB.SW
Market Capitalization7.598.946.816,00 USD
CountrySwitzerland
IndicesSTOXX EUROPE 600
SectorsSpecialty Chemicals
Raw Data SourceIFRS in Millionen CHF
Stock Split2019-04-25,7034.000000/7033.000000; 2001-06-29,20.000000/1.000000
Internetwww.bachem.com


Description of the company

Bachem Holding AG, a technology-based biochemicals company, provides services to the pharmaceutical and biotechnology industries primarily in Switzerland, the United States, Germany, Ireland, the United Kingdom, Austria, Japan, and internationally. It develops and manufactures peptide and oligonucleotides as active pharmaceutical ingredients (APIs), as well as biochemicals for research purposes. The company offers research products, which include peptides, amino acid derivatives, and biochemicals for peptide research; and custom synthesis services. It also provides API products comprising generic APIs used in the fields of cancer, diabetes, obesity, fertility, and others; and peptides for new chemical entities. In addition, the company offers oligonucleotide-based APIs, as well as customer support services. Bachem Holding AG was founded in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG is a subsidiary of Ingro Finanz AG.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.bachem.com


NEWS